Search

Your search keyword '"Roos RA"' showing total 489 results

Search Constraints

Start Over You searched for: Author "Roos RA" Remove constraint Author: "Roos RA"
489 results on '"Roos RA"'

Search Results

3. Suicidal ideation in a European Huntington's disease population

4. NMDA receptor gene variations as modifiers in Huntington disease: a replication study

6. Beta-Defensin genomic copy number does not influence the age of onset in Huntington's Disease

7. The V471A polymorphism in autophagy-related gene ATG7 modifies age at onset specifically in Italian Huntington disease patients

8. Observing Huntington's disease: the European Huntington's Disease Network's REGISTRY

9. Observing Huntington's Disease: the European Huntington's Disease Network's REGISTRY

10. Normal and mutant HTT interact to affect clinical severity and progression in Huntington disease

12. β-Defensin Genomic Copy Number Does Not Influence the Age of Onset in Huntington's Disease

13. Discrepancies in reporting the CAG repeat lengths for Huntington's disease

14. NMDA receptor gene variations as modifiers in Huntington disease

15. NMDA receptor gene variations as modifiers in Huntington disease: a replication study

17. Weight loss in Huntington disease increases with higher CAG repeat number

20. Caregiver education in Parkinson's disease: formative evaluation of a standardized program in seven European countries.

24. Huntington's disease: a clinical review

30. The influence of gender on phenotype and disease progression in patients with Huntington's disease

31. Apathy predicts rate of cognitive decline over 24 months in premanifest Huntington's disease.

32. Executive impairment is associated with unawareness of neuropsychiatric symptoms in premanifest and early Huntington's disease.

33. Neurofilament light protein in blood predicts regional atrophy in Huntington disease.

34. Survival End Points for Huntington Disease Trials Prior to a Motor Diagnosis.

35. Cross-sectional and longitudinal voxel-based grey matter asymmetries in Huntington's disease.

36. Recommendations for the Use of Automated Gray Matter Segmentation Tools: Evidence from Huntington's Disease.

37. Topological length of white matter connections predicts their rate of atrophy in premanifest Huntington's disease.

38. White matter predicts functional connectivity in premanifest Huntington's disease.

39. Current Pharmacological Approaches to Reduce Chorea in Huntington's Disease.

40. The Effect of Music Therapy in Patients with Huntington's Disease: A Randomized Controlled Trial.

41. Plasma Cytokine Levels in Relation to Neuropsychiatric Symptoms and Cognitive Dysfunction in Huntington's disease.

42. Natural variation in sensory-motor white matter organization influences manifestations of Huntington's disease.

43. Early grey matter changes in structural covariance networks in Huntington's disease.

44. Progression of motor subtypes in Huntington's disease: a 6-year follow-up study.

46. Suicidality in Huntington's Disease: A Qualitative Study on Coping Styles and Support Strategies.

47. Medication Use in Early-HD Participants in Track-HD: an Investigation of its Effects on Clinical Performance.

48. Large-scale brain network abnormalities in Huntington's disease revealed by structural covariance.

49. Participants at the Leiden Site of the REGISTRY Study: A Demographic Approach.

50. Short-interval observational data to inform clinical trial design in Huntington's disease.

Catalog

Books, media, physical & digital resources